Mira Therapeutics
Company Details
Linkedin ID:
miratherapeutics
Website:
Employees number:
1
Number of followers:
224
NAICS:
621
Industry Type:
Homepage:
miratx.app
IP Addresses:
0
Company ID:
MIR_4526436
Scan Status:
In-progress
Mira Therapeutics Company CyberSecurity Posture
miratx.app
Mira Therapeutics is a digital health company changing the way people recover and grow from trauma. Through a combination of self-management tools, symptom tracking, and a therapist platform, Mira Therapeutics empowers users to better cope with their symptoms, and enables therapists to deliver personalized, measurement-based care. Our first product, the Mira App, helps users manage their symptoms when they occur, educates about trauma, and tracks events and triggers that inform treatment decisions.
Mira Therapeutics A.I CyberSecurity Scoring
Mira Therapeutics Risk Score (AI oriented)Between 750 and 799
Mira Therapeutics
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
Mira Therapeutics Global Score (TPRM)XXXX
Mira Therapeutics
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
Mira Therapeutics Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
Mira Therapeutics Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for Mira Therapeutics
Incidents vs Mental Health Care Industry Average (This Year)
No incidents recorded for Mira Therapeutics in 2026.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Mira Therapeutics in 2026.
Incident Types Mira Therapeutics vs Mental Health Care Industry Avg (This Year)
No incidents recorded for Mira Therapeutics in 2026.
Incident History — Mira Therapeutics (X = Date, Y = Severity)
Mira Therapeutics cyber incidents detection timeline including parent company and subsidiaries
Mira Therapeutics Company Subsidiaries
Mira Therapeutics is a digital health company changing the way people recover and grow from trauma. Through a combination of self-management tools, symptom tracking, and a therapist platform, Mira Therapeutics empowers users to better cope with their symptoms, and enables therapists to deliver personalized, measurement-based care. Our first product, the Mira App, helps users manage their symptoms when they occur, educates about trauma, and tracks events and triggers that inform treatment decisions.
Loading...
Mira Therapeutics Similar Companies
Summit's Edge, LLC
Summit’s Edge is committed to providing holistic, restorative, and evidence-based treatment of mental illness, inclusive of all populations. We are passionate about the advocacy of mental wellness, creating connections within the mental health community, as well as the professional growth and develo
BeBold Recovery: Drug and Alcohol Rehab Center | Substance Abuse Addiction Treatment In Virginia
BeBold Recovery is a premier outpatient addiction treatment center in Norfolk, Virginia, dedicated to transforming lives through evidence-based care, compassion, and community. We specialize in a range of services, including Partial Hospitalization Programs (PHP), Intensive Outpatient Programs (IOP
Baltimore Crisis Response, Inc.
BCRI is a 501(c)(3) private non-profit behavioral health and crisis services organization. Since 1992, we have helped countless individuals overcome mental health and substance use disorders, regardless of ability to pay or time of day. We envision a world of thriving communities where healing and m
NorthPoint Professional Counseling
As a professional counselor I have listened to many couples express feelings of frustration and hurt because of their inability to effectively communicate with one another. Studies prove that communication breakdown is a major source of conflict, one that can eventually lead to other problems in th
The Bridge
Founded in 1954, The Bridge is a non profit 501 (c) (3) organization that has developed into one of New York City’s premier rehabilitation agencies. The Bridge provides mental health and substance abuse treatment, housing, vocational training and job placement, healthcare, education and creative ar
Redpoint
Redpoint is the premier out-patient mental health and drug addiction treatment facility located across Colorado. We empower our clients to live lives of community, purpose, and recovery. Our licensed professionals understand the complex challenges associated with starting anew. And, collectively, we
Silver Hill New York
Silver Hill New York’s Intensive Outpatient Program (IOP) focuses on treating clients with complex mental health and substance use needs, such as those with multiple co-occurring diagnoses and impaired personality function. Located in the heart of Midtown Manhattan, Silver Hill New York enables clie
UCLA Depression Grand Challenge
The UCLA Depression Grand Challenge (DGC) was initiated to cut the burden of depression in half by 2050 and eliminate it by the end of the century. Depression is recognized by the World Health Organization as the leading cause of disability worldwide. Please visit https://grandchallenges.ucla.edu
Inclusive Therapists
Inclusive Therapists offers a safer, simpler way to find a culturally responsive, social justice-oriented therapist. We center the needs of Black, Indigenous, and People of Color (BIPOC) and the 2SLGBTQIA+ community. We honor the full neurodiversity spectrum and advocate for mental health care acce
.png)
Mira Therapeutics CyberSecurity News
October 16, 2025 07:00 AM
MIRA Pharmaceuticals Announces Oral Mira-55 Outperformed Injected Morphine in Normalizing Pain and Reducing Inflammation, Supporting Its Planned IND for Chronic Inflammatory Pain
Findings show oral Mira-55 fully normalized pain and significantly reduced inflammation, supporting IND plans and reinforcing MIRA's...
October 16, 2025 07:00 AM
$70.3B Market: MIRA's Oral Mira-55 Normalized Pain, Cut Inflammation; Supports IND
Oct 16, 2025 — Oral Mira-55 normalized pain and reduced inflammation via CB2 in a formalin model, outperforming injected morphine;...
September 30, 2025 07:00 AM
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals
Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs including...
September 22, 2025 03:30 PM
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD.
July 11, 2025 07:00 AM
Breakthrough: MIRA's New Obesity Drug Achieves 30% Weight Loss While Reversing Anxiety in Trial Data
MIRA Pharmaceuticals (NASDAQ:MIRA) announced promising new preclinical results for SKNY-1, their oral drug candidate for obesity and...
June 30, 2025 07:00 AM
EXCLUSIVE: MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal Study
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Monday revealed new animal study results from SKNY-1, a next-generation oral therapeutic.
May 08, 2025 07:00 AM
EXCLUSIVE: Mira Pharmaceuticals Board Approves SKNY Pharma Acquisition, Establishing Combined Enterprise Value Over $60 Million
Mira Pharmaceuticals, Inc.'s (NASDAQ:MIRA) Board of Directors unanimously approved on Thursday the planned acquisition of SKNY...
April 16, 2025 07:00 AM
EXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal Study
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) on Wednesday released data demonstrating the efficacy of the oral ketamine analog, Ketamir-2,...
March 24, 2025 07:00 AM
EXCLUSIVE: MIRA Pharmaceuticals Signs To Acquire SKNY Pharmaceuticals, Expand Pipeline Into Weight Loss And Smoking Cessation Drug
On Monday, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) signed a binding letter of intent (LOI) to acquire SKNY Pharmaceuticals,...
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
Mira Therapeutics CyberSecurity History Information
Official Website of Mira Therapeutics
The official website of Mira Therapeutics is https://miratx.app.
Mira Therapeutics’s AI-Generated Cybersecurity Score
According to Rankiteo, Mira Therapeutics’s AI-generated cybersecurity score is 752, reflecting their Fair security posture.
How many security badges does Mira Therapeutics’ have ?
According to Rankiteo, Mira Therapeutics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Has Mira Therapeutics been affected by any supply chain cyber incidents ?
According to Rankiteo, Mira Therapeutics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.
Does Mira Therapeutics have SOC 2 Type 1 certification ?
According to Rankiteo, Mira Therapeutics is not certified under SOC 2 Type 1.
Does Mira Therapeutics have SOC 2 Type 2 certification ?
According to Rankiteo, Mira Therapeutics does not hold a SOC 2 Type 2 certification.
Does Mira Therapeutics comply with GDPR ?
According to Rankiteo, Mira Therapeutics is not listed as GDPR compliant.
Does Mira Therapeutics have PCI DSS certification ?
According to Rankiteo, Mira Therapeutics does not currently maintain PCI DSS compliance.
Does Mira Therapeutics comply with HIPAA ?
According to Rankiteo, Mira Therapeutics is not compliant with HIPAA regulations.
Does Mira Therapeutics have ISO 27001 certification ?
According to Rankiteo,Mira Therapeutics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Mira Therapeutics
Mira Therapeutics operates primarily in the Mental Health Care industry.
Number of Employees at Mira Therapeutics
Mira Therapeutics employs approximately 1 people worldwide.
Subsidiaries Owned by Mira Therapeutics
Mira Therapeutics presently has no subsidiaries across any sectors.
Mira Therapeutics’s LinkedIn Followers
Mira Therapeutics’s official LinkedIn profile has approximately 224 followers.
Mira Therapeutics’s Presence on Crunchbase
No, Mira Therapeutics does not have a profile on Crunchbase.
Mira Therapeutics’s Presence on LinkedIn
Yes, Mira Therapeutics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/miratherapeutics.
Cybersecurity Incidents Involving Mira Therapeutics
As of January 21, 2026, Rankiteo reports that Mira Therapeutics has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Mira Therapeutics has an estimated 5,283 peer or competitor companies worldwide.
Mira Therapeutics CyberSecurity History Information
How many cyber incidents has Mira Therapeutics faced ?
Total Incidents: According to Rankiteo, Mira Therapeutics has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Mira Therapeutics ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
SummaryA command injection vulnerability (CWE-78) has been found to exist in the `wrangler pages deploy` command. The issue occurs because the `--commit-hash` parameter is passed directly to a shell command without proper validation or sanitization, allowing an attacker with control of `--commit-hash` to execute arbitrary commands on the system running Wrangler. Root causeThe commitHash variable, derived from user input via the --commit-hash CLI argument, is interpolated directly into a shell command using template literals (e.g., execSync(`git show -s --format=%B ${commitHash}`)). Shell metacharacters are interpreted by the shell, enabling command execution. ImpactThis vulnerability is generally hard to exploit, as it requires --commit-hash to be attacker controlled. The vulnerability primarily affects CI/CD environments where `wrangler pages deploy` is used in automated pipelines and the --commit-hash parameter is populated from external, potentially untrusted sources. An attacker could exploit this to: * Run any shell command. * Exfiltrate environment variables. * Compromise the CI runner to install backdoors or modify build artifacts. Credits Disclosed responsibly by kny4hacker. Mitigation * Wrangler v4 users are requested to upgrade to Wrangler v4.59.1 or higher. * Wrangler v3 users are requested to upgrade to Wrangler v3.114.17 or higher. * Users on Wrangler v2 (EOL) should upgrade to a supported major version.
Risk Information
cvss4
Base: 7.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
Description
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle VM VirtualBox accessible data as well as unauthorized access to critical data or complete access to all Oracle VM VirtualBox accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:L).
Risk Information
cvss3
Base: 8.1
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:L
Description
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
Description
Vulnerability in the Oracle VM VirtualBox product of Oracle Virtualization (component: Core). Supported versions that are affected are 7.1.14 and 7.2.4. Easily exploitable vulnerability allows high privileged attacker with logon to the infrastructure where Oracle VM VirtualBox executes to compromise Oracle VM VirtualBox. While the vulnerability is in Oracle VM VirtualBox, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in takeover of Oracle VM VirtualBox. CVSS 3.1 Base Score 8.2 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H).
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:C/C:H/I:H/A:H
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=miratherapeutics' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
